Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Carcinoma in Situ and CDH1[original query] |
---|
Germline CDH1 mutations in bilateral lobular carcinoma in situ. British journal of cancer 2014 Feb 110 (4): 1053-7. Petridis C, Shinomiya I, Kohut K, Gorman P, Caneppele M, Shah V, Troy M, Pinder S E, Hanby A, Tomlinson I, Trembath R C, Roylance R, Simpson M A, Sawyer E |
BRCA2 carriers with male breast cancer show elevated tumour methylation. BMC cancer 2017 9 17 (1): 641. Deb Siddhartha, Gorringe Kylie L, Pang Jia-Min B, Byrne David J, Takano Elena A, , Dobrovic Alexander, Fox Stephen |
PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression. Breast cancer research : BCR 2017 1 19 (1): 7. Shah Vandna, Nowinski Salpie, Levi Dina, Shinomiya Irek, Kebaier Ep Chaabouni Narda, Gillett Cheryl, Grigoriadis Anita, Graham Trevor A, Roylance Rebecca, Simpson Michael A, Pinder Sarah E, Sawyer Elinor |
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Aug . Guindalini Rodrigo Santa Cruz, Zheng Yonglan, Abe Hiroyuki, Whitaker Kristen, Yoshimatsu Toshio F, Walsh Tom, Schacht David, Kulkarni Kirti, Sheth Deepa, Verp Marion S, Bradbury Angela R, Churpek Jane, Obeid Elias, Mueller Jeffrey, Khramtsova Galina, Liu Fang, Raoul Akila, Cao Hongyuan, Romero Iris L, Hong Susan, Livingston Robert, Jaskowiak Nora, Wang Xiaoming, Debiasi Marcio, Pritchard Colin C, King Mary-Claire, Karczmar Gregory, Newstead Gillian M, Huo Dezheng, Olopade Olufunmilayo |
Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Jul 28 (7): 1162-1168. Petridis Christos, Arora Iteeka, Shah Vandna, Moss Charlotte L, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study. Breast cancer (Tokyo, Japan) 2023 3 . Kikuchi Mari, Gomi Naoya, Ueki Arisa, Osako Tomo, Terauchi Takas |
Spectrum of histopathologic findings in risk-reducing bilateral prophylactic mastectomy in patients with and without BRCA mutations. Human pathology 2023 11 . Baris Boyraz, Amy |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: